Investing

Investment analysis, share recommendations, and market insights.

Premium

“HOT” stock: Telix Pharmaceuticals (TLX)

In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains that it appears as though Telix Pharmaceuticals (TLX) is back in the uptrend and current prices are a buying opportunity.

Maureen Jordan · March 27, 2025
Premium

Is private credit safe?

Is investing in private credit is worth the risk and just how safe is it? And if you’re an investor or planning to invest, what should you look out for?

Paul Rickard · March 24, 2025
Premium

Four gold ETFs

Gold broke through the US$3000 barrier for the first time ever, with gold in Australian dollars trading at $4,819.47 an ounce. For investors who want an exposure to gold, here are four ASX-listed gold exchange Traded Products (ETPs also known as ETFs). These four securities are the simplest and easiest ways to do so, simply using your stockbroking account.

James Dunn · March 24, 2025
Premium

Is it time to buy stocks?

Provided they don’t get out of hand and create a real global trade war, these Trump tariffs are actually creating a buying opportunity. The next question is — what should I buy?

Peter Switzer · March 17, 2025
Premium

Three stocks for the bounce that top my “buy” list

The “buy the dip” strategy has worked very successfully since the Covid crash, and for the decade leading up to that. The several factors driving this dip have some time to play out and that’s why I don’t think the correction is over. But I am looking to buy, and these three stocks top my “buy” list.

Paul Rickard · March 17, 2025

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.